The medical world is witnessing a significant shift in blood sugar therapy with the arrival of GLP-1 transdermal devices. These devices offer a possibly more user-friendly alternative to shots of GLP-1 receptor agonists, reducing the requirement of daily needle pricks. The innovation delivers the drug directly through the epidermis, arguably boosti